Electromagnetic Signals from Retinoic Acid Treat Human Cancer Cells
August 31, 2018
This post reviews the publication titled “Experimental Finding on the Electromagnetic Information Transfer of Specific Molecular Signals Mediated Through the Aqueous System on Two Human Cellular Models” by Foletti et al. This study is an extension of their previous findings related to Electromagnetic Information Transfer.
What is the purpose of the study?
The purpose of the study is to further investigate whether water is able to record, store, and transfer electromagnetic information signals from biologically active substances, in this case, retinoic acid, to cells.
What did the authors do?
The authors examined the effects of the electromagnetic information signals from retinoic acid (a differentiating agent) on the morphological and biochemical properties of two types of human cancer cells: neuroblastoma (LAN-5) and teratocarcinoma (NT2/D1).
In essence, the two types of cancer cells were grown in an aqueous medium which was “charged” with electromagnetic signals from retinoic acid and after 5 days of incubation various properties of the cells were examined. To compare, controlled experiments (i.e. cancer cells grown in “non-charged” aqueous medium) were also performed.
What did the study reveal?
One finding was that there was a significant difference between the control cells and the electronically treated cells with respect to cell metabolism. In fact, the cells grown in the “charged” aqueous medium showed a decrease in metabolic activity compared to the control group.
Another finding was that the electronically treated cells were morphologically different than the control group – the cells grown in the “charged” aqueous medium looked like they were chemically treated with retinoic acid.
Overall the authors concluded that using the electromagnetic signals from retinoic acid and an aqueous system, it is possible to effect and treat cancer cells.
What does this mean?
The evidence presented by Foletti et al. are in line with the pioneering work of Jacques Benveniste and although further experimental work is needed to fully understand the biophysical mechanisms involved in the entire process, these results do provide preliminary evidence that supports the future use of informational medicine, including infoceuticals, in the clinical world.
To read the entire publication, please click here.